Premium
FDA warns Alkermes about OD risk on Vivitrol ads
Author(s) -
Knopf Alison
Publication year - 2019
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32566
Subject(s) - food and drug administration , advertising , business , internet privacy , administration (probate law) , medicine , environmental health , political science , law , computer science
The Food and Drug Administration (FDA) has warned Alkermes for omitting warnings about serious risks of Vivitrol in a print ad for the medication. The warning was posted Dec. 11 on the FDA's website.